| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |